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A B S T R A C T
Primary gastric non Hodgkin lymphoma (PGNHL) is a distinct group of extranodal lymphomas with interesting geo-
graphical distribution and variable prevalence in different countries. We analysed epidemyological data of our patients
with PGNHL in Primorsko-goranska County. Clinical data of 30 patients with PGNHL diagnosed and treated in Clini-
cal Hospital Center of Rijeka, Croatia between January 1995 and December 2005 were prospectively analyzed. We used
statistical analysis (t-test, c2-test) for small groups. Out of 30 pts with PGNHL, 19 were born in Primorsko-goranska
County, part of Croatia situated by the Adriatic sea which consists of three regions: City of Rijeka, Islands and Gorski
Kotar. 6 of 19 patients (31.6%) were originally from Gorski Kotar which made incidence rate of PGNHL in Gorski Kotar
7 times higher than in other two regions. Many authors emphasized that relative frequency of PGNHL is very variable in
various countries and regions. Geographical distribution of our patients was very surprising because Gorski Kotar is the
region with lowest number of citizens, rural area without any known pollutants, and ecologically one of the most pre-
served microsystem in this part of Croatia. Gorski Kotar is known to be an endemic region for multiple sclerosis and
lyme borreliosis. Is it for PGNHL too?
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gastric non-Hodgkin’s lymphoma
Introduction
Primary gastric non Hodgkin lymphoma (PGNHL) is
a rare tumor accounting for 30–69% of all extra nodal
lymphomas and 1–10% of gastric malignant neoplasm.
They form a distinct group of tumors with interesting
geographical distribution and variable prevalence in dif-
ferent countries1,2.
While the clinical and experimental knowledge con-
cerning PGNHL is increasing, there is a scarcity of epide-
miological data in that field. In the past two decades,
there has been a sharp rise in the incidence of nodal and
esspecially of extranodal primary lymphomas, represent-
ing 33% of all incident lymphomas in the US in 2000.
Fisher et al. stated that the incidence of non-Hodgkin’s
lymphoma (NHL) has doubled over the past two decades
in the US and most other westernized countries. Some of
the reasons for that observation is improved cancer re-
porting, changes in lymphoma classification, and increa-
ses in AIDS-associated lymphomas but more than a half
cases with NHL could not be contribute to that reasons.
Non-Hodgkin’s lymphoma rates have steadily increa-
sed 30% each year in the US from 1970s to the mid
1990s. Most other Westernized countries in which regis-
try data are available have reported similar trends. The-
se increases in NHL have been observed in males and fe-
males, whites and nonwhites, and all age groups except
the very young. With the exception of skin malignancies,
such temporal increases in cancer incidence are un-
precedented2,3.
Since 1980, NHL incidence in males, aged 25–54, has
undergone dramatic escalation, mostly related to the
HIV epidemic, but other, HIV negative lymphomas have
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been in dramaticall escalation too. Current evidence sug-
gests that factors or conditions that precipitate either
chronic antigenic stimulation or immunosuppression may
provide a preferential milieu for development of NHL.
High rates of lymphoma have been observed among
individuals with autoimmune disease, organ transplants,
and primary or acquired immunodeficiency4–7. Several
pathogens have been linked to the risk of lymphoma, in-
cluding Helicobacter pylori, Epstein-Barr virus, human
immunodeficiency virus, human T-cell lymphotropic vi-
rus-1, hepatitis C virus, simian virus 40, and human her-
pes virus 8 which infections is described in patients with
primary effusion lymphomas8–10. Whether these micro-
bes are responsible for specific genetic mutations that
initiate tumor growth, antigenic stimulation leading to
B-cell proliferation and increased potential of random
cell replication errors or immunosuppression, which the-
reby promotes tumor growth, has not been clearly delin-
eated.
Other exogenous factors as chemicals, agricultural ex-
posures, hair dyes, and blood transfusions11–14, as well as
genetic factors15 have been implicated in lymphomage-
nesis.
Many authors showed conection of PGNHL with pos-
sible ethyological agents. We wanted to analyse geo-
graphic distribution of PGNHL and analyse their con-
nection with possible parameters previously described in
the literature.
Patients and Methods
A population-based sample of patients diagnosed and
treated in Clinical Hospital Center of Rijeka, Croatia be-
tween January 1995 and December 2005 was prospec-
tively analyzed.
Hospital archives have been collected by standardized
questionnaires prepared previously for a registry. Clini-
cal data of 30 patients with PGNHL has been collected.
For statistics and incidence rate we used data from
Goverment population registry and the Department of
Epidemiology and Medical Statistics, University of Rije-
ka, Croatia.
Statistical analysis (t-test, c2-test) for small groups,
percentage, tabular and cartography analysis has been
made16.
All data has been analyzed by Statistica (ANOVAe)
program in Windows XP operational system.
Results
Over a period of 10 years, 30 patients with primary
gastric non Hodgkin lymphoma (PGNHL) were recorded
in UniversityHospital Center Rijeka, Rijeka, Croatia.
Out of 30 pts with PGNHL, 19 (10 men, 9 women, mean
age 62.1 y) were born in Primorsko-goranska County. A to-
tal population of Primorsko-goranska County is 331,090
citizens which mean that incidence of PGNHL in our
population is 0.574/100.000 per year.
Primorsko-goranska County is a part of Croatia situ-
ated by the Adriatic Sea which consists of three regions:
City of Rijeka, Islands and Gorski Kotar. 6 of 19 patients
(31.6%) were originally from Gorski Kotar which made
incidence rate of PGNHL in Gorski Kotar 4 to 9 times
higher than compared with whole region or other two re-
gions respectively (Table 1). The higher concentration of
the patients with gastric lymphoma in Gortski Kotar is
also seen on the map (Figure 1).
We compared clinical data of patients from Gorski
Kotar with other patients with PGNHL seen at our clinic
and there were no significant differences among those
two groups in age, sex, clinical presentation, laboratory
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TABLE 1
DEMOGRAPHYC CHARACTERISTICS AND INCIDENCE RATE OF PRIMARY GASTRIC NON HODGKIN LYMPHOMA (PGNHL) IN COUNTY
OF PRIMORJE-GORSKI KOTAR
Surface area (km2) Population
Regional density
(Residents/km2)
Patients with
PGNHL
Incidence rate
County of Primorje-Gorski Kotar 3893 331,090 85 19 0.57
Rijeka and coast (Crikvenica Opatija) 1279 255,182 200 12 0.47
Islands 1342 45,372 34 1 0.22
Gorski kotar 1272 30,536 24 6 1.96
Fig. 1. Geographic distribution of patients with primary gastric
non-Hodgkin lymphoma in County of Primorje-Gorski Kotar.
Part inside the circle represents Gorski Kotar.
parameters, histological type of lymphoma, remission
and survival rate.
Patients from whole region were predominantly from
higher age groups (mean age 62,1 years). The distribu-
tion of histological subtypes was as follows: marginal
zone B-cell lymphomas (MZBL), 65%; diffuse large-cell
B-cell lymphoma (DLBL), 29%; and mixed forms, 6%. H.
pylori could be detected histologically in 79% of all cases,
91% of MZBL cases and 62% of DLBL cases.
Discussion
Primary gastric non Hodgkin lymphoma (PGNHL) is
one of the major sites of extra nodal NHL. Previous re-
searches tried to analyze its epidemiological and etiologi-
cal characteristics and concluded that PGNHL had vari-
able geographic distribution.
In the United States NHL represents 4% of all can-
cers. The majority of NHL cases arise in lymph nodes,
but primary extra nodal disease accounts for 20–30% of
all cases. The most frequent primary extranodal sites are
the stomach. The incidence of non-Hodgkin’s lymphoma
(NHL), particularly at certain extra nodal sites is rising
rapidly. Leukemia Research Fund Data Collection Sur-
vey which covers many parts of England and Wales re-
ported Age-standardized incidence rates of gastrointesti-
nal NHL at all sites (0.58/105 per year),and gastric lym-
phoma (0.24/105 per year). It was the lowest rate gastric
NHL in Europe. Analysis showed that the incidence of
gastrointestinal NHL significantly increased by 2.7% per
annum. Time-trend analyses showed annual increases in
incidence rates for gastric (6.3%) and small bowel (5.9%).
The reasons for these increases are poorly understood.
After accounting for the impact of changes in diagnosis
and well-established risk factors, there remains an unex-
plained increase in incidence of more than 40% over the
past 40 years. Incidence differ according sex (50% higher
for males), age (elderly) and race (35% higher among
whites). Rates of NHL historically have been about 40%
higher in urban counties than in rural counties, but the
excess has become smaller (about 15–25%) in recent
years and is attributed to a more rapid increase in the in-
cidence of NHL in rural areas.
The incidence rates among various countries are very
variable. NHL in the United States tends to exceed those
of most other countries. The difference is particularly
striking for follicular lymphoma, which constitutes 20%
of cases in Western countries but is relatively rare in de-
veloping countries, China, and Japan. Geographical dif-
ferences in etiologic or host factors may play a role in
these international differences. The increase in incidence
has been more rapid in rural than urban regions of the
United States and might be associated with exposures to
pesticides17–19.
Non Hodgkin lymphoma occurs worldwide and is
strongly correlated with socioeconomic status. The dis-
ease is most common in developed countries, with US
rates exceeding those of most other countries in the
world. Notable are the unusually low rates of NHL re-
ported in Thailand and China (2–3/100,000). The occur-
rence of NHL subtypes varies by geographic area. For in-
stance, Burkitt’s lymphoma is most common in tropical
Africa; the highest rates of adult T-cell lymphoma occur
in southwest Japan and the Caribbean; and follicular
lymphomas are extremely rare in Latin America20.
Extranodal lymphomas especially primary gastric non
Hodgkin lymphoma (PGNHL) also has variable inci-
dence rates. Higher incidence has been noticed in north-
ern Italy21 especially in Feltre22 where were 13 times
more cases of PGL in 1986–91 than in the UK communi-
ties, and in USA23 where compared with whites, Asians/
Pacific Islanders had higher rates of NHL of the stom-
ach. In Germany were similar to that in other European
countries, except England where rates were lower24.
The annual incidence rate of NHL in 1995–1999, esti-
mated from the Surveillance, Epidemiology, and End Re-
sults (SEER) Program of the National Cancer Institute,
was 19.1 cases per 100,000 persons, while crude inci-
dence for NHL in Primorsko-goranska County is 14.5/
100,000 citizens per year25.
We noticed unusually high incidence of PGNHL in
Gorski Kotar which was not explainable to us at this
point and we would like to share our results and compare
them to other studies. Gorski Kotar is the region with
lowest number of citizens, rural area, without any known
pollutants, and ecologically one of the most preserved mi-
crosystems in this part of Croatia. In the same time
Gorski Kotar has been known for years to be endemic re-
gion for multiple sclerosis (MS)26 and Lyme borreliosis.
We speculate a possibility that those two illnesses could
be in some way connected with extranodal lymphomas. Is
it possible that certain cytogenetic susscceptibility, im-
munodeficiency, in combination with some environmen-
tal agents, esspecially some viral or microorganismmate-
rial in certain geographic area in certain moment lead to
either lymphomagenensis or multiple sclerosis? Are they
only sharing the same factors? Are they the similar dis-
eases in different clinical presentation?
The challenge in the future would be to research the
connection among those diseases and conduct a prospec-
tive study on the larger number of examiniees.
Conclusion
Incidence rate of gastric lymphoma in Primorsko-
-goranska County was similar to incidence rate in other
European countries, but it was very unusually concen-
trated in Gorski Kotar. Geographical distribution of our
patients was very surprising because Gorski Kotar is also
known to be an endemic region for multiple sclerosis and
Lyme borreliosis. Is it for PGNHL too? Our results
arouse questions of the possible conection of those three
illnesses known to be endemic for the same region. Our
future researches focused on NHL risks and causal fac-
tors are ongoing in that direction.
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GORSKI KOTAR – ENDEMSKO PODRU^JE ZA PRIMARNI LIMFOM @ELUCA?
S A @ E T A K
Primarni gastri~ni non Hodgkin limfom (PGNHL) rijedak je tumor (30–69% svih ekstranodalnih limfoma i 1–10%
malignih neoplazmi `eluca) s interesantnom geografskom distribucijom i razli~itom prevalencijom u raznim zemljama.
Prospektivnom analizom klini~kih podataka 30 pacijenata lije~enih zbog PGNHL u KBC Rijeka, uo~ili smo da je od 30
pacijenata s PGNHL 19 ro|eno u Primorsko goranskoj `upaniji (PG@) koja se sastoji od tri regije: Grad Rijeka, Otoci i
Gorski Kotar. 6 of 19 pacijenata (31,6%) ro|eni su u Gorskom Kotaru {to obzirom na povr{inu tih podru~ja, broj
stanovnika i gusto}u naseljenosti ~ini incidenciju PGNHL 7 puta ve}om nego u ostale dvije regije. Gorski Kotar je
ruralno, ekolo{ki o~uvano podru~je s najmanjim brojem stanovnika i gusto}om naseljenosti u PG@, poznato kao
endemsko podru~je za multiplu sklerozu i Lyme boreliozu. Prospektivna studija na ve}em broju bolesnika pokazat }e
radi li se o endemskom podru~ju i za PGNHL ili druge limfome.
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